{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T04:40:13Z","timestamp":1756788013373,"version":"3.44.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the efficacy of mirabegron in patients with intramural ureteral stones (6\u201310\u00a0mm).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We prospectively randomized 92 patients with intramural ureteral stones into two groups. Patients in the mirabegron group received 50\u00a0mg of mirabegron daily, while those in the tamsulosin group received 0.4\u00a0mg tamsulosin daily. All patients were required to use the Urinary Sensation Scale (USS) to assess the urinary urgency and the Visual Analog Scale (VAS) to assess pain. Patients were followed until stone expulsion or for up to 4 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All of 80 patients were included in this study. 41 patients in mirabegron group and 39 patients in tamsulosin group as control. The average expulsion time was shorter in mirabegron group than in tamsulosin group (8.4 \u00b1 2.9 vs. 11.2 \u00b1 3.1 days, <jats:italic>P<\/jats:italic> &amp;lt; 0.0001). The stone expulsion rate (SER) was higher in mirabegron group than in tamsulosin group on 1 and 2 weeks (36.6% vs. 15.4%, <jats:italic>P<\/jats:italic> = 0.031 and 75.6% vs. 43.6%, <jats:italic>P<\/jats:italic> = 0.004). However, the SER on 4 weeks had no statistical difference between two groups (<jats:italic>P<\/jats:italic> &amp;gt; 0.05). Post-treatment VAS and USS scores were lower in mirabegron group than tamsulosin group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Mirabegron not only accelerates the expulsion of intramural ureteral stones but also relieves renal colic and vesical irritability.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1639032","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T04:10:40Z","timestamp":1756786240000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mirabegron for intramural ureteral stones with vesical irritability: a prospective study"],"prefix":"10.3389","volume":"16","author":[{"given":"Mengjun","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s11255-019-02142-0","article-title":"Adjunction of tamsulosin or mirabegron before semi-rigid ureterolithotripsy improves outcomes: prospective, randomized single-blind study","volume":"51","author":"Bayar","year":"2019","journal-title":"Int. urology Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s11255-019-02368-y","article-title":"Efficacy of silodosin or mirabegron in medical expulsive therapy for ureteral stones: a prospective, randomized-controlled study","volume":"52","author":"Bayar","year":"2020","journal-title":"Int. urology Nephrol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.eururo.2007.09.012","article-title":"Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones","volume":"53","author":"Bensalah","year":"2008","journal-title":"Eur. Urol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.eururo.2019.07.053","article-title":"Medical expulsive therapy for urinary stones: future trends and knowledge gaps","volume":"76","author":"De Coninck","year":"2019","journal-title":"Eur. Urol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1111\/bph.14121","article-title":"Mirabegron: potential off target effects and uses beyond the bladder","volume":"175","author":"Dehvari","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B6","first-page":"286","article-title":"Comparing silodosin and mirabegron as medical expulsive therapy for distal ureteral calculus: a prospective, randomised study","volume":"77","author":"Faridi","year":"2024","journal-title":"Central Eur. J. urology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1007\/s12325-021-01902-8","article-title":"Efficacy of vibegron and mirabegron for overactive bladder: a systematic literature review and indirect treatment comparison","volume":"38","author":"Kennelly","year":"2021","journal-title":"Adv. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/01.ju.0000081424.44254.45","article-title":"Clinical characteristics of ureteral calculi detected by nonenhanced computerized tomography after unclear results of plain radiography and ultrasonography","volume":"170","author":"Kobayashi","year":"2003","journal-title":"J. urology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12894-015-0050-5","article-title":"The beneficial effect of alpha-blockers for ureteral stent-related discomfort: systematic review and network meta-analysis for alfuzosin versus tamsulosin versus placebo","volume":"15","author":"Kwon","year":"2015","journal-title":"BMC Urol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00240-013-0599-y","article-title":"Tamsulosin and tolterodine in the medical expulsive therapy for intramural ureteral stones with vesical irritability: a prospective randomized study","volume":"41","author":"Lv","year":"2013","journal-title":"Urolithiasis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1089\/end.2017.0563","article-title":"Comparing the efficacy of tolterodine and gabapentin versus placebo in catheter-related bladder discomfort after percutaneous nephrolithotomy: a randomized clinical trial","volume":"32","author":"Maghsoudi","year":"2018","journal-title":"J. Endourol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/iju.12093","article-title":"Expression and functional role of \u03b23\u2010adrenoceptors in the human ureter","volume":"20","author":"Matsumoto","year":"2013","journal-title":"Int. J. Urology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/00005392-199909010-00014","article-title":"Time to stone passage for observed ureteral calculi: a guide for patient education","volume":"162","author":"Miller","year":"1999","journal-title":"J. urology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00063110-200206000-00007","article-title":"Comparison of stone size and response to analgesic treatment in predicting outcome of patients with renal colic","volume":"9","author":"Prina","year":"2002","journal-title":"Eur. J. Emerg. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ajem.2015.12.068","article-title":"Urinary obstruction is an important complicating factor in patients with septic shock due to urinary infection","volume":"34","author":"Reyner","year":"2016","journal-title":"Am. J. Emerg. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1210\/jc.2011-3492","article-title":"Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management","volume":"97","author":"Sakhaee","year":"2012","journal-title":"J. Clin. Endocrinol. and Metabolism"},{"key":"B17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/j.ajkd.2023.03.017","article-title":"Kidney stone pathophysiology, evaluation and management: core curriculum 2023","volume":"82","author":"Shastri","year":"2023","journal-title":"Am. J. kidney Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1089\/end.2009.0670","article-title":"The role for active monitoring in urinary stones: a systematic review","volume":"24","author":"Skolarikos","year":"2010","journal-title":"J. endourology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00240-018-1075-5","article-title":"Efficacy of mirabegron in medical expulsive therapy","volume":"47","author":"Solakhan","year":"2019","journal-title":"Urolithiasis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1056\/NEJMcp030813","article-title":"Clinical practice. Acute renal colic from ureteral calculus","volume":"350","author":"Teichman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41581-020-0320-7","article-title":"Determining the true burden of kidney stone disease","volume":"16","author":"Thongprayoon","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.eururo.2016.07.024","article-title":"Medical expulsive therapy for ureterolithiasis: the EAU recommendations in 2016","volume":"71","author":"T\u00fcrk","year":"2017","journal-title":"Eur. Urol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00345-024-04799-4","article-title":"Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial","volume":"42","author":"Wada","year":"2024","journal-title":"World J. Urol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2362.2008.02008.x","article-title":"Therapeutic challenges of urosepsis","volume":"38","author":"Wagenlehner","year":"2008","journal-title":"Eur. J. Clin. Investigation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1464-410X.2010.09801.x","article-title":"A multicentre, prospective, randomized trial: comparative efficacy of tamsulosin and nifedipine in medical expulsive therapy for distal ureteric stones with renal colic","volume":"108","author":"Ye","year":"2011","journal-title":"BJU Int."},{"key":"B26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.eururo.2017.10.033","article-title":"Efficacy and safety of tamsulosin in medical expulsive therapy for distal ureteral stones with renal colic: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"73","author":"Ye","year":"2018","journal-title":"Eur. Urol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1639032\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T04:10:41Z","timestamp":1756786241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1639032\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":26,"alternative-id":["10.3389\/fphar.2025.1639032"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1639032","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"article-number":"1639032"}}